Review Finds Insufficient Evidence Supporting Corticosteroid Irrigation for CRS With Nasal Polyps
October 12th 2022A search of the peer-reviewed literature turned up inconsistent findings on the effectiveness of corticosteroid irrigation for the treatment of chronic rhinosinusitis (CRS) with nasal polyps.
Read More
Climate Change, Health Disparities Take the Stage at CHEST 2022
October 12th 2022As with many medical meetings, some of the presentations from the annual American College of Chest Physicians event will be livestreamed or on demand for later viewing, but the organizers have stressed the importance of coming together for the first time since 2019.
Read More
Dr Subani Chandra on the Value of In-Person Connections During CHEST 2022
October 11th 2022CHEST 2022 is being held in Nashville, Tennessee, beginning October 16, and Subani Chandra, MD, FCCP, the chair of the Scientific Program Committee, discusses why meeting in real life as opposed to virtually is energizing, even if medical conferences are hectic.
Watch
ICER to Assess Clinical Effectiveness, Value of 2 NASH Treatments
October 11th 2022There are no FDA-approved therapies for nonalcoholic steatohepatitis (NASH), but there are many being developed. Resmetirom and obeticholic acid are both being reviewed by the FDA with decisions expected in 2023.
Read More
Sepsis, Septic Shock Likely Increase Risk of Adverse Outcomes in PAH
October 11th 2022Investigators for this study analyzed outcomes among patients hospitalized with pulmonary arterial hypertension (PAH) who have higher risks of adverse health outcomes, in particular sepsis and septic shock.
Read More
Technology Is on Tap at ACCC National Oncology Conference
October 11th 2022The sessions align with the yearlong theme selected by this year’s ACCC president, David R. Penberthy, MD, MBA, when he took the helm in March: “Leveraging Technology to Transform Cancer Care Delivery and the Patient Experience.”
Read More
Researchers Explore Similarities, Differences in Guidelines for PsA Treatment
October 11th 2022In the last 2 years, the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) and the European Alliance of Associations for Rheumatology (EULAR) have updated their recommendations to integrate guidance for new treatment options.
Read More
Task Force Calls for Prioritizing Safety, Privacy in AID Use; Seeks Harmony Among Regulators
October 10th 2022Along with its position statement in Diabetologia, the group outlined recommendations that seek greater structure and consistency for automated insulin delivery (AID) manufacturers as they develop products for use by persons with type 1 and type 2 diabetes.
Read More
Assessing Surgical Complications in Management of Hidradenitis Suppurativa
October 10th 2022Approximately 1 in 10 patients with hidradenitis suppurativa (HS) experienced complications related to surgery for HS management, in which extensive resection, using skin flaps or skin grafts as a closure method, was associated with a higher incidence of complications.
Read More
Teva, the largest US supplier of Adderall, expects shortages to continue for the next 2-3 months; FDA expands use of Boostrix for immunization during the third trimester of pregnancy to prevent pertussis in infants; over the last 3 decades, Black women had a 40% higher breast cancer death rate compared with White women.
Read More
AMCP Nexus 2022 to Address Evolving Value-Based Frameworks, Shared Decision-Making
October 10th 2022The annual fall meeting of AMCP Nexus 2022 will feature a keynote from one of the top physician-executives in health care, the specialty pharmaceutical pipeline, and insights for managed care stakeholders in selecting and integrating cost-effective, value-based care frameworks.
Read More
For COPD Treated in Primary Care, ICS May Be Inappropriately Prescribed
October 8th 2022Inhaled corticosteroid (ICS) therapy was not the most appropriate treatment for many patients with chronic obstructive pulmonary disease (COPD) in a review of patient records at 2 US primary care clinics.
Read More